Source:http://linkedlifedata.com/resource/pubmed/id/11096444
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
2000-12-11
|
pubmed:abstractText |
The safety of lentiviral vectors for clinical applications is still a major concern. The gag-pol expression plasmids and the lentiviral vectors used in previous studies contain homologous regions, which constitute a risk for recombination events. Synthetic gag-pol genes of human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) were therefore constructed, in which the codon usage was optimized for expression in human cells without altering the amino acid sequences. The synthetic gag-pol genes allowed efficient expression of these genes in the absence of Rev and the 5' untranslated leader region. Both the HIV-1 and the SIV synthetic gag-pol expression plasmids could mediate transduction of an SIV vector into nondividing human cells with titers of about 10(6) transducing units/ml. Similar titers were obtained with a four-plasmid vector-packaging system based on HIV-1. Using a biological assay, homologous recombination events between the synthetic gag-pol expression plasmids and an SIV vector were undetectable and in comparison with a previously used gag-pol expression plasmid at least approximately 100-fold less frequent. By eliminating regions of homology and sequences involved in packaging, synthetic gag-pol genes should improve the safety profile of lentiviral vectors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5' Untranslated Regions,
http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, gag-pol,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, gag,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, rev,
http://linkedlifedata.com/resource/pubmed/chemical/rev Gene Products, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1043-0342
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2403-13
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11096444-5' Untranslated Regions,
pubmed-meshheading:11096444-Cells, Cultured,
pubmed-meshheading:11096444-Fusion Proteins, gag-pol,
pubmed-meshheading:11096444-Gene Expression Regulation, Viral,
pubmed-meshheading:11096444-Gene Products, gag,
pubmed-meshheading:11096444-Gene Products, rev,
pubmed-meshheading:11096444-Genetic Vectors,
pubmed-meshheading:11096444-HIV-1,
pubmed-meshheading:11096444-Humans,
pubmed-meshheading:11096444-Lentivirus,
pubmed-meshheading:11096444-Plasmids,
pubmed-meshheading:11096444-Recombination, Genetic,
pubmed-meshheading:11096444-Simian immunodeficiency virus,
pubmed-meshheading:11096444-Transduction, Genetic,
pubmed-meshheading:11096444-Virus Replication,
pubmed-meshheading:11096444-rev Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2000
|
pubmed:articleTitle |
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
|
pubmed:affiliation |
Institut für Medizinische Mikrobiologie and Hygiene, Universität Regensburg, D-93053 Regensburg, Germany. ralf.wagner@klinik.uni-ragansburg.da
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|